Company CVAbout Vaishali Pharma Ltd 
Vaishali Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name "Vaishali Pharma Private Limited" on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.
Company Coordinates
Company Details
706 to 709 7th Floor Aravali, Business Centre Borivali(W) Mumbai Maharashtra : 400092
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 10.72 Cr
Number of Shares
5.36 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
15-Oct-2024
5.36
10.72
42876852
2
Stock Split
15-Oct-2024
10.72
21.44
53596065
2
Bonus Issue
02-Jan-2024
1.07
10.72
123000
10
Preferential basis
22-May-2023
1.06
10.60
50000
10
Preferential basis
17-Oct-2019
1.05
10.55
3954828
10
Bonus Issue
17-Oct-2019
1.05
10.55
3954828
10
Bonus Issue
22-Aug-2017
65.91
6.59
1976000
10
Public Issues
10-May-2017
46.15
4.62
1615385
10
Conversion of Loans
31-Mar-2017
3
3.00
2500000
10
Bonus
31-Dec-2012
5
0.50
400000
10
Conversion of Loans
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Atul Arvindbhai Vasani (21.1%)
Highest Public shareholder
Sapan Anil Shah (6.39%)
Individual Investors Holdings
67.25%
Board of Directors
Management
Designation
Remuneration
Atul Vasani
Chairman & Managing Director
54.0 lacs
Jagruti Vasani
Whole-time Director
12.0 lacs
Dewansh Vasani
Executive Director
7.84 lacs
Ashvin Jamnadas Ganatra
Independent Director
29.7 k
Manish Bhagwandas Ved
Independent Director
29.7 k
Vishwa Mekhia
Company Sec. & Compli. Officer
0
Pratik Vikram Jakhelia
Independent Director
20.9 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases of stock-in-trade
50.98784
0%
Purchases of stock-in-trade
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Traded Goods
65.33
96.18%
Commission Income
1.73
2.54%
Export Incentive
0.70
1.03%
Traded Goods
Traded Goods
Commission Income
Commission Income
Export Incentive
Export Incentive
Stock DNARevenue and Profits:
Net Sales:
33 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
Pharmaceuticals & Biotechnology
INR Cr (Micro Cap)
NA (Loss Making)
NA
0.00%
0.00
0.00%
0.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
